Guardion Health Sciences Q1 EPS $(3.71) Misses $(0.88) Estimate, Sales $3.00M Miss $3.12M Estimate
Portfolio Pulse from Benzinga Newsdesk
Guardion Health Sciences (NASDAQ:GHSI) reported a significant miss in Q1 EPS at $(3.71) versus the $(0.88) estimate and a slight miss in sales at $3.00M against the $3.12M estimate. This represents a 983.33% decrease in earnings and a 5.85% decrease in sales from the same period last year.
May 13, 2024 | 9:04 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Guardion Health Sciences reported a significant miss in Q1 earnings and sales, with EPS at $(3.71) vs. $(0.88) estimate and sales at $3.00M vs. $3.12M estimate, indicating a substantial decrease in performance compared to the same period last year.
The significant miss in both earnings per share and sales compared to analyst estimates, coupled with a drastic decrease in earnings compared to the previous year, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100